{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "ATHE",
        "Security_Name": "Alterity Therapeutics Limited - American Depositary Shares",
        "Listing_Exchange": "Q",
        "Market_Category": "S",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "D",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "ATHE",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 1,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 1,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 4,
        "previousClose": 0.36,
        "open": 0.3481,
        "dayLow": 0.34,
        "dayHigh": 0.3696,
        "regularMarketPreviousClose": 0.36,
        "regularMarketOpen": 0.3481,
        "regularMarketDayLow": 0.34,
        "regularMarketDayHigh": 0.3696,
        "payoutRatio": 0,
        "beta": 1.02225,
        "volume": 224991,
        "regularMarketVolume": 224991,
        "averageVolume": 92303,
        "averageVolume10days": 274840,
        "averageDailyVolume10Day": 274840,
        "bid": 0.365,
        "ask": 0.3499,
        "bidSize": 800,
        "askSize": 2900,
        "marketCap": 15144442,
        "fiftyTwoWeekLow": 0.29,
        "fiftyTwoWeekHigh": 1.05,
        "priceToSalesTrailing12Months": 2.9558637,
        "fiftyDayAverage": 0.3568,
        "twoHundredDayAverage": 0.56265,
        "currency": "USD",
        "fromCurrency": null,
        "lastMarket": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [],
            "earningsDate": []
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2019,
                    "revenue": 4951167,
                    "earnings": -12337830
                },
                {
                    "date": 2020,
                    "revenue": 0,
                    "earnings": -13456800
                },
                {
                    "date": 2021,
                    "revenue": 4339599,
                    "earnings": -15309353
                },
                {
                    "date": 2022,
                    "revenue": 5123525,
                    "earnings": -12847061
                }
            ],
            "quarterly": [
                {
                    "date": "3Q2021",
                    "revenue": 1179599,
                    "earnings": -3291780
                },
                {
                    "date": "4Q2021",
                    "revenue": 1179599,
                    "earnings": -3291780
                },
                {
                    "date": "1Q2022",
                    "revenue": 1382164,
                    "earnings": -3131751
                },
                {
                    "date": "2Q2022",
                    "revenue": 1382164,
                    "earnings": -3131751
                }
            ]
        },
        "financialCurrency": "AUD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": []
        }
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-08-03T00:00:00.000Z",
                "firm": "Ladenburg Thalmann",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2022-06-23T00:00:00.000Z",
                "firm": "Goldman Sachs",
                "toGrade": "Neutral",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-08-20T00:00:00.000Z",
                "firm": "Benchmark",
                "toGrade": "Speculative Buy",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "DELAYED",
        "postMarketChangePercent": -0.0282938,
        "postMarketChange": -0.0099,
        "postMarketTime": "2023-01-07T00:41:33.000Z",
        "postMarketPrice": 0.34,
        "postMarketSource": "FREE_REALTIME",
        "regularMarketChangePercent": -0.028055575,
        "regularMarketChange": -0.010100007,
        "regularMarketTime": "2023-01-06T20:59:43.000Z",
        "priceHint": 4,
        "regularMarketPrice": 0.3499,
        "regularMarketDayHigh": 0.3696,
        "regularMarketDayLow": 0.34,
        "regularMarketVolume": 224991,
        "averageDailyVolume10Day": 274840,
        "averageDailyVolume3Month": 92303,
        "regularMarketPreviousClose": 0.36,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 0.3481,
        "exchange": "NCM",
        "exchangeName": "NasdaqCM",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "ATHE",
        "underlyingSymbol": null,
        "shortName": "Alterity Therapeutics Limited",
        "longName": "Alterity Therapeutics Limited",
        "currency": "USD",
        "quoteSourceName": "Nasdaq Real Time Price",
        "currencySymbol": "$",
        "fromCurrency": null,
        "lastMarket": null,
        "marketCap": 15144442
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 4,
        "enterpriseValue": -17929440,
        "profitMargins": -2.50746,
        "floatShares": 31602664,
        "sharesOutstanding": 40114600,
        "sharesShort": 247187,
        "sharesShortPriorMonth": 264672,
        "sharesShortPreviousMonthDate": 1663200000,
        "dateShortInterest": 1665705600,
        "sharesPercentSharesOut": 0.0062,
        "heldPercentInsiders": 0,
        "heldPercentInstitutions": 0.01809,
        "shortRatio": 1.75,
        "beta": 1.02225,
        "category": null,
        "bookValue": 1.02,
        "priceToBook": 0.3430392,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2022-06-30T00:00:00.000Z",
        "nextFiscalYearEnd": "2024-06-30T00:00:00.000Z",
        "mostRecentQuarter": "2022-06-30T00:00:00.000Z",
        "netIncomeToCommon": -12847061,
        "trailingEps": -0.66,
        "lastSplitFactor": "1:6",
        "lastSplitDate": "2016-03-24T00:00:00.000Z",
        "enterpriseToRevenue": -3.499,
        "enterpriseToEbitda": 1.158
    },
    "summaryProfile": {
        "address1": "460 Bourke Street",
        "address2": "Level 3",
        "city": "Melbourne",
        "state": "VIC",
        "zip": "3000",
        "country": "Australia",
        "phone": "61 3 9349 4906",
        "fax": "61 3 9349 4906",
        "website": "https://alteritytherapeutics.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.",
        "fullTimeEmployees": 12,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 0.3499,
        "targetHighPrice": 4,
        "targetLowPrice": 2,
        "targetMeanPrice": 3,
        "targetMedianPrice": 3,
        "recommendationMean": 1.5,
        "recommendationKey": "strong_buy",
        "numberOfAnalystOpinions": 2,
        "totalCash": 34806800,
        "totalCashPerShare": 0.868,
        "ebitda": -15484139,
        "totalDebt": 117489,
        "quickRatio": 6.792,
        "currentRatio": 7.069,
        "totalRevenue": 5123525,
        "debtToEquity": 0.331,
        "revenuePerShare": 0.12,
        "returnOnAssets": -0.25854,
        "returnOnEquity": -0.38966,
        "grossProfits": 4758860,
        "freeCashflow": -6458512,
        "operatingCashflow": -12337274,
        "revenueGrowth": 0.125,
        "grossMargins": 0.92882,
        "ebitdaMargins": 0,
        "operatingMargins": -3.02565,
        "profitMargins": -2.50746,
        "financialCurrency": "AUD"
    }
}